George Bickerstaff - Net Worth and Insider Trading
George Bickerstaff Net Worth
The estimated net worth of George Bickerstaff is at least $2 Million dollars as of 2024-09-20. George Bickerstaff is the Director of CareDx Inc and owns about 37,736 shares of CareDx Inc (CDNA) stock worth over $1 Million. George Bickerstaff is the Director of Innoviva Inc and owns about 53,762 shares of Innoviva Inc (INVA) stock worth over $1 Million. George Bickerstaff is also the Director of Sio Gene Therapies Inc and owns about 6,250 shares of Sio Gene Therapies Inc (SIOX) stock worth over $2,988. Details can be seen in George Bickerstaff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George Bickerstaff has not made any transactions after 2022-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of George Bickerstaff
George Bickerstaff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George Bickerstaff owns 6 companies in total, including CareDx Inc (CDNA) , Innoviva Inc (INVA) , and Sio Gene Therapies Inc (SIOX) among others .
Click here to see the complete history of George Bickerstaff’s form 4 insider trades.
Insider Ownership Summary of George Bickerstaff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDNA | CareDx Inc | 2022-02-28 | director |
| INVA | Innoviva Inc | 2019-04-24 | director |
| SIOX | Sio Gene Therapies Inc | 2018-08-09 | director |
 | | 2017-03-21 | director |
| | 2017-02-16 | director |
| | 2006-03-02 | director |
George Bickerstaff Latest Holdings Summary
George Bickerstaff currently owns a total of 3 stocks. Among these stocks, George Bickerstaff owns 37,736 shares of CareDx Inc (CDNA) as of February 28, 2022, with a value of $1 Million and a weighting of 51.53%. George Bickerstaff owns 53,762 shares of Innoviva Inc (INVA) as of February 27, 2019, with a value of $1 Million and a weighting of 48.33%. George Bickerstaff also owns 6,250 shares of Sio Gene Therapies Inc (SIOX) as of August 9, 2018, with a value of $2,988 and a weighting of 0.14%.
Latest Holdings of George Bickerstaff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CDNA | CareDx Inc | 2022-02-28 | 37,736 | 29.88 | 1,127,552 |
| INVA | Innoviva Inc | 2019-02-27 | 53,762 | 19.67 | 1,057,499 |
| SIOX | Sio Gene Therapies Inc | 2018-08-09 | 6,250 | 0.48 | 2,988 |
Holding Weightings of George Bickerstaff
George Bickerstaff Form 4 Trading Tracker
According to the SEC Form 4 filings, George Bickerstaff has made a total of 5 transactions in CareDx Inc (CDNA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in CareDx Inc is the sale of 25,000 shares on February 28, 2022, which brought George Bickerstaff around $977,750.
According to the SEC Form 4 filings, George Bickerstaff has made a total of 0 transactions in Innoviva Inc (INVA) over the past 5 years. The most-recent trade in Innoviva Inc is the acquisition of 15,000 shares on February 27, 2019, which cost George Bickerstaff around $238,500.
According to the SEC Form 4 filings, George Bickerstaff has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 3,125 shares on August 9, 2018, which cost George Bickerstaff around $51,750.
Insider Trading History of George Bickerstaff
- 1
George Bickerstaff Trading Performance
GuruFocus tracks the stock performance after each of George Bickerstaff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George Bickerstaff is -6.75%. GuruFocus also compares George Bickerstaff's trading performance to market benchmark return within the same time period. The performance of stocks bought by George Bickerstaff within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George Bickerstaff's insider trading performs compared to the benchmark.
Performance of George Bickerstaff
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.54 | | | | | |
| Relative Return to S&P 500(%) | -4.33 | | | | | |
George Bickerstaff Ownership Network
George Bickerstaff Owned Company Details
What does CareDx Inc do?
Who are the key executives at CareDx Inc?
George Bickerstaff is the director of CareDx Inc. Other key executives at CareDx Inc include Chief Business Officer Alexander L Johnson , director & President and CEO Peter Maag , and See Remarks Reginald Seeto .
CareDx Inc (CDNA) Insider Trades Summary
Over the past 18 months, George Bickerstaff made no insider transaction in CareDx Inc (CDNA). Other recent insider transactions involving CareDx Inc (CDNA) include a net sale of 39,834 shares made by Reginald Seeto , a net sale of 42,984 shares made by Peter Maag , and a net sale of 95,254 shares made by Alexander L Johnson .
In summary, during the past 3 months, insiders sold 130,806 shares of CareDx Inc (CDNA) in total and bought 0 shares, with a net sale of 130,806 shares. During the past 18 months, 178,072 shares of CareDx Inc (CDNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 178,072 shares.
CareDx Inc (CDNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
CareDx Inc Insider Transactions
George Bickerstaff Mailing Address
Above is the net worth, insider trading, and ownership report for George Bickerstaff. You might contact George Bickerstaff via mailing address: C/o Vion Pharmaceuticals, Inc., 4 Science Park, New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
